计算溶液所需的质量、体积或浓度。
Acetazolamide sodium 是一种碳酸酐酶 (CA) IX 抑制剂,对 hCA IX 的 IC50 为 30 nM。Acetazolamide 具有利尿、抗高血压和抗淋球菌活性。
Acetazolamide sodium is a carbonic anhydrase ( CA ) IX inhibitor with an IC 50 of 30 nM for hCA IX . Acetazolamide sodium has diuretic, antihypertensive and anti-gonococcal activities.
In Vitro
Acetazolamide also inhibits hCA II with an IC 50 of 130 nM. Acetazolamide (Ace) is a small heteroaromatic sulfonamide that binds to various carbonic anhydrases with high affinity, acting as a carbonic anhydrase (CA) inhibitor. Compared with the control group, the high Acetazolamide concentration (AceH, 50 nM), Cisplatin (Cis; 1 µg/mL) and Cis combined with the low Acetazolamide concentration (AceL, 10 nM) treatments significantly reduces viability of Hep-2 cells. Treatment with the Acetazolamide/Cis combination significantly increases the expression levels of P53, as both AceL+Cis and AceH+Cis treatments result in significantly increased P53 protein expression levels compared with the control group. The Ace/Cis combination treatment significantly reduces the bcl-2/bax expression ratio, and increases the expression of caspase-3 protein, compared with the control group. AceL, AceH, Cis and AceL+Cis treatments significantly reduce the bcl-2/bax ratio compared with the control group. Combined Ace and Cis treatment effectively promotes apoptosis in Hep-2 cells. Combined treatment with Ace/Cis markedly decreases the expression of AQP1 mRNA in Hep-2 cells. Both AceH and AceL+Cis treatments decrease the expression of aquaporin-1 (AQP1) mRNA in Hep-2 cells compared with the control group. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Acetazolamide (40 mg/kg) significantly potentiates the inhibitory effect of MS-275 on tumorigenesis in neuroblastoma (NB) SH-SY5Y xenografts. Acetazolamide (40 mg/kg) and/or MS-275 treatment reduce expression of HIF1-α and CAIX in NB SH-SY5Y xenograft. Acetazolamide (40 mg/kg), MS-275 and Acetazolamide+MS-275 reduce expression of mitotic and proliferative markers in NB SH-SY5Y xenografts.\nAcetazolamide (50 mg/kg; PO, for 3 days) significantly reduces the gonococcal load in the vagina of infected mice by 90% . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:IC 50 : 30 nM (hCA IX), 130 nM (hCA II)
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机氮化合物 |
| 类(Class) | 有机氮化合物 |
| 亚类(Subclass) | N-芳基酰胺 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | N-乙酰芳胺 |
| 其他上位类(Alternative Parents) | 噻二唑类 磺酰基 有机磺酸及其衍生物 杂芳族化合物 乙酰胺 仲羧酸酰胺 氮杂环化合物 有机光子化合物 有机两性离子 有机钠盐 有机氧化物 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 芳香族杂单环化合物 |
| 取代基(Substituents) | 乙酰胺 - 芳香族杂单环化合物 - 氮杂环 - 吡唑 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 杂芳香族化合物 - 烃衍生物 - N-乙酰基芳基胺 - 有机碱金属盐 - 有机氧化物 - 有机氧化合物 - 有机盐 - 有机钠盐 - 有机磺酸或其衍生物 - 有机双性离子 - 有机杂环化合物 - 有机氧化合物 - 有机氮化合物 - 有机磺酸或其衍生物 - 有机硫化合物 - 醛基 - 磺酰基 - 噻二唑 |
| 描述(Description) | 该化合物属于有机化合物中的N-乙酰芳胺类。这类化合物是乙酰胺的衍生物,其一个或多个酰胺氢被芳基取代。 |
| 外部描述符(External Descriptors) | organic sodium salt |